Display Settings:

Format

Send to:

Choose Destination
    Indian J Dermatol Venereol Leprol. 2005 Jan-Feb;71(1):9-13.

    Dexamethasone-cyclophosphamide pulse therapy in systemic lupus erythematosus.

    Source

    Departments of Skin and V. D., Dr. S. N. Medical College, Jodhpur, Rajasthan, India.

    Abstract

    BACKGROUND AND AIMS:

    Therapy systemic lupus erythematosus (SLE) has been generally discouraging. Methyl-prednisolone pulse therapy has been used for various connective tissue disorders. We used intravenous dexamethasone cyclophosphamide pulse therapy to treat SLE.

    METHODS:

    Fourteen patients (10 females and 4 males) between the age of 15-48 years with definite or classical clinical criteria laid by American Rheumatism Association criteria were treated by Dexamethasone-Cyclophosphamide pulse (DCP) therapy at our center.

    RESULTS:

    It was possible to induce a complete clinical remission with DCP therapy in most of the patients thereby offering them life free from disease and drugs. The side effects commonly observed with conventional daily dose regimen of corticosteroids were not present or were mild.

    CONCLUSIONS:

    Almost all patients had good response after 3-4 pulses to allow them a normal life style. Fever, malar rash and oral ulceration responded early but photosensitivity, discoid rash, alopecia and joint pains took some more time.

    PMID:
    16394353
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for Medknow Publications and Media Pvt Ltd

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk